Denali Therapeutics Inc. (DNLI)

Trade DNLI now with
1/11/2021 8:43:54 AM Denali Therapeutics Appoints Nancy Thornberry To Board
10/7/2020 8:52:14 AM Denali Therapeutics Closes Collaboration And Share Purchase Agreements With Biogen
8/6/2020 8:55:37 AM Biogen, Denali To Co-develop Small Molecule Inhibitors Of LRRK2 For Parkinson's Disease.
1/8/2019 9:05:57 AM Denali Therapeutics Begins Dosing In Phase 1b Clinical Study Of DNL747 In Patients With ALS
1/8/2019 8:07:13 AM Cygnal Therapeutics Appoints Pearl Huang As CEO
12/10/2018 9:07:41 AM Denali Therapeutics Unveils First Patient Dosed In Phase 1b Study Of DNL201 For Parkinson’s Disease
11/1/2018 2:09:31 AM Denali Therapeutics, Sanofi To Develop RIPK1 Inhibitors For Treatment Of Neurological And Inflammatory Diseases
10/3/2018 9:07:04 AM CENTOGENE And Denali Announce Strategic Collaboration To Recruit LRRK2 Patients For Clinical Trials
8/7/2018 4:34:36 PM Denali Therapeutics Appoints Dana Andersen As Chief Technical And Manufacturing Officer